Stallergenes AG
Stallergenes AG is a Biotech company based in Dietlikon (Zurich) recorded by Swissmedic as the authorisation holder for 21 human medicines. That places it 92 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Allergen: Therapeutikum.
Key facts
| Sector | Biotech |
|---|---|
| City | Dietlikon |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 21 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Stallergenes Greer |
| Activity | Not available |
| Website | stallergenesgreer.ch |
Medicines authorised in Switzerland
Stallergenes AG is recorded by Swissmedic as the authorisation holder for 21 human medicines. The table shows 21 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
21 of 21 authorisations
Frequently asked questions
How many medicines does Stallergenes AG have authorised in Switzerland?
Stallergenes AG is recorded by Swissmedic as the authorisation holder for 21 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Stallergenes AG based?
The Swiss location recorded for Stallergenes AG is Dietlikon, Zurich.
Is Stallergenes AG a Swissmedic authorisation holder?
Yes. Stallergenes AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.